Ray Dalio’s Protolabs PRLB Stock Holding History

Ray Dalio’s Portfolio PRLB Stock Details PRLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,690	Closed	-$438K	–	1140
2026 Q1	$438K	Buy	+7,690	New	+$446K	﹤0.01%	903

Other funds holding PRLB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Ray Dalio's PRLB Position: Q2 2026 in Review

Ray Dalio sold out of Protolabs (PRLB) in Q2 2026, closing a stake of 7,690 shares — an estimated $438K sold.

Ray Dalio first reported a position in PRLB in Q1 2026 and held it in 1 quarter. The position peaked at $438K in Q1 2026. 277 funds tracked by Wall St. Rank hold PRLB as of Q2 2026.

Ray Dalio reported no remaining Protolabs position as of Q2 2026 after selling out during the quarter.
Ray Dalio sold 7,690 Protolabs shares in Q2 2026, an estimated $438K.
Ray Dalio first reported a position in Protolabs in Q1 2026 and held it in 1 quarter.
Ray Dalio's Protolabs position peaked at $438K in Q1 2026.
277 funds tracked by Wall St. Rank held Protolabs as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.